Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil

Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis

(2021) Bradley J. Langford et al.   CLINICAL MICROBIOLOGY AND INFECTION

Multidrug-Resistant Bacterial Infections in Geriatric Hospitalized Patients before and after the COVID-19 Outbreak: Results from a Retrospective Observational Study in Two Geriatric Wards

(2021) Beatrice Gasperini et al.   Antibiotics-Basel

Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings

(2021) Mentor Ali Ber Lucien et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Systematic research to overcome newly emerged multidrug resistant bacteria

(2020) Yoshichika Arakawa   MICROBIOLOGY AND IMMUNOLOGY

COVID-19, superinfections and antimicrobial development: What can we expect?

(2020) Cornelius J Clancy et al.   CLINICAL INFECTIOUS DISEASES

Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing

(2020) Timothy M Rawson et al.   CLINICAL INFECTIOUS DISEASES

COVID-19 and the potential long-term impact on antimicrobial resistance

(2020) Timothy M Rawson et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Virtually Perfect? Telemedicine for Covid-19

(2020) Judd E. Hollander et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibiotic treatment for COVID-19 complications could fuel resistant bacteria

(2020) Sara Reardon   SCIENCE

How covid-19 is accelerating the threat of antimicrobial resistance

(2020) Jeremy Hsu   BMJ-British Medical Journal

On the front lines of coronavirus: the Italian response to covid-19

(2020) Marta Paterlini   BMJ-British Medical Journal

Mitigating the wider health effects of covid-19 pandemic response

(2020) Margaret Douglas et al.   BMJ-British Medical Journal

The Novel Coronavirus COVID-19 Outbreak: Global Implications for Antimicrobial Resistance

(2020) Aimee K. Murray   Frontiers in Microbiology

Could the COVID-19 pandemic aggravate antimicrobial resistance?

(2020) Luana Rossato et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Tackling antimicrobial resistance in the COVID-19 pandemic

(2020) Haileyesus Getahun et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis

(2020) Bradley J. Langford et al.   CLINICAL MICROBIOLOGY AND INFECTION

COVID-19 will further exacerbate global antimicrobial resistance

(2020) Esabelle Lo Yan Yam   JOURNAL OF TRAVEL MEDICINE

Antimicrobial use, drug-resistant infections and COVID-19

(2020) Timothy M. Rawson et al.   NATURE REVIEWS MICROBIOLOGY

Decreased Influenza Activity During the COVID-19 Pandemic — United States, Australia, Chile, and South Africa, 2020

(2020) Sonja J. Olsen et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Antimicrobial Stewardship Program, COVID-19, and Infection Control: Spread of Carbapenem-Resistant Klebsiella Pneumoniae Colonization in ICU COVID-19 Patients. What Did Not Work?

(2020) Beatrice Tiri et al.   Journal of Clinical Medicine

Spread of OXA-48-producing Klebsiella pneumoniae among COVID-19-infected patients: The storm after the storm

(2020) Isidro García-Meniño et al.   Journal of Infection and Public Health

Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions — New Jersey, February–July 2020

(2020) Stephen Perez et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Impact of the COVID-19 Pandemic on Antimicrobial Consumption and Hospital-Acquired Candidemia and Multidrug-Resistant Bloodstream Infections

(2020) Ana Guisado-Gil et al.   Antibiotics-Basel

Ceftazidime/avibactam as salvage therapy for infections caused by Enterobacteriales co-resistant to carbapenems and polymyxins

(2019) Thaís Guimarães et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe

(2018) Mike Sharland et al.   LANCET INFECTIOUS DISEASES

Executive Summary: Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America

(2016) Tamar F. Barlam et al.   CLINICAL INFECTIOUS DISEASES

Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy

(2012) M. Tumbarello et al.   CLINICAL INFECTIOUS DISEASES